MSI cancers have a good prognosis but not all colorectal cancers with BRAF mutation and CIMP silence MLH1 and those that remain microsatellite stable (MSS) have a particularly poor prognosis [9]. The gene discussed is BRAF; the disease is colorectal cancer.